Prostate cancer Prostate cancer
Conditions
Interventions
Consent for participation in the study will be obtained at the time of the decision on the date of total prostatectomy about 2 to 4 weeks prior to the day of surgery, and instruction in pelvic floor m
Prostate cancer
Sponsors
Takeuchi Shinichi
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Patients with a confirmed diagnosis of prostate cancer Patients who underwent RARP Patients who were instructed to perform pelvic floor muscle exercises before and after RARP Patients who have given consent to participate in this study
Exclusion criteria
Exclusion criteria: Patients without a confirmed diagnosis of prostate cancer Patients who can not perform pelvic floor muscle exercises Patients who did not give consent to participate in this study (including patients in the control group who refused the use of their medical information in the study by opting out) Patients whom the physician considers unlikely to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative incontinence | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival (OS) Disease-free survival (DFS) Progression-free survival (PFS) Side effects Quality of life (based on questionnaire) Functional voiding as quantified by urodynamic testing Intraoperative findings Previous history Comorbidities | — |
Contacts
Public ContactShinichi Takeuchi
Gifu University Hospital
Outcome results
None listed